BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Alios BioPharma 

260 East Grand Avenue
2nd Floor
South San Francisco  California  94080  U.S.A.
Phone: 650-635-5500 Fax: 650-872-0584


SEARCH JOBS




Industry
Biotechnology






 Company News
Johnson & Johnson (JNJ) Announces Completion Of Alios BioPharma Acquisition 11/10/2014 8:00:38 AM
Alios BioPharma To Present Preclinical Data On Its Anti-HCV Nucleotides AL-335 And AL-516 At The 2014 American Association for Study of Liver Diseases Annual Meeting 11/7/2014 12:21:49 PM
Alios BioPharma Presented Positive Results Of Its Anti-RSV Nucleoside Analog AL-8176 In A Phase 2 Challenge Study In Adults Infected With Respiratory Syncytial Virus (RSV) At IDWeek 10/13/2014 10:57:06 AM
Alios BioPharma’s Corporate Venture Backers Ride RSV (And Hep C) To A Big Payday 10/2/2014 6:47:06 AM
Johnson & Johnson (JNJ) Bags SSF's Alios BioPharma For $1.7 Billion Cash 9/30/2014 6:55:16 AM
Alios BioPharma Announces Upcoming RSV & HCV Scientific Presentations 9/15/2014 2:39:41 PM
Alios BioPharma Presents Data On Its Anti-HCV Nucleotide AL-335 At Special Conference On Hepatitis C 9/15/2014 11:58:51 AM
Retroscreen Conducts Landmark hVIVO Human Challenge Model Study Of AL-8176 In RSV For Alios BioPharma 7/28/2014 8:22:35 AM
Alios BioPharma Reports Positive Results Of Its Anti-RSV Nucleoside Analog AL-8176 In A Phase 2 Challenge Study In Adults Infected With Respiratory Syncytial Virus (RSV) 7/24/2014 1:08:44 PM
South San Francisco's Alios BioPharma Raises $41 Million In Series B Financing 4/7/2014 10:57:52 AM
123